How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,247 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. A systematic review of technology-assisted depression screening tools for cancer patients

A systematic review of technology-assisted depression screening tools for cancer patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites (...) . Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed

2019 PROSPERO

22. Rationale and study protocol for a multi-component Health Information Technology (HIT) screening tool for depression and post-traumatic stress disorder in the primary care setting. Full Text available with Trip Pro

Rationale and study protocol for a multi-component Health Information Technology (HIT) screening tool for depression and post-traumatic stress disorder in the primary care setting. The prevalence rate of depression in primary care is high. Primary care providers serve as the initial point of contact for the majority of patients with depression, yet, approximately 50% of cases remain unrecognized. The under-diagnosis of depression may be further exacerbated in limited English-language proficient (...) (LEP) populations. Language barriers may result in less discussion of patients' mental health needs and fewer referrals to mental health services, particularly given competing priorities of other medical conditions and providers' time pressures. Recent advances in Health Information Technology (HIT) may facilitate novel ways to screen for depression and other mental health disorders in LEP populations. The purpose of this paper is to describe the rationale and protocol of a clustered randomized

2017 Contemporary clinical trials Controlled trial quality: uncertain

23. Developing and validating a perinatal depression screening tool in Kenya blending Western criteria with local idioms: A mixed methods study. (Abstract)

Developing and validating a perinatal depression screening tool in Kenya blending Western criteria with local idioms: A mixed methods study. Routine screening for perinatal depression is not common in most primary health care settings. The U.S. Preventive Services Task Force only recently updated their recommendation on depression screening to specifically recommend screening during the pre- and postpartum periods. While practitioners in high-income countries can respond to this new (...) recommendation by implementing one of several existing depression screening tools developed in Western contexts, such as the Edinburgh Postnatal Depression Scale (EPDS) or the Patient Health Questionnaire-9 (PHQ-9), these tools lack strong evidence of cross-cultural equivalence, validity for case finding, and precision in measuring response to treatment in developing countries. Thus, there is a critical need to develop and validate new screening tools for perinatal depression that can be used by lay health

2017 Journal of Affective Disorders

24. The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder. Full Text available with Trip Pro

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder. To validate the THINC-integrated tool (THINC-it)-a freely available, patient-administered, computerized screening tool integrating subjective and objective measures of cognitive function in adults with major depressive disorder (MDD).Subjects aged 18 to 65 years (n = 100) with recurrent MDD experiencing a major depressive episode of at least moderate (...) severity were evaluated and compared to age-, sex-, and education-matched healthy controls (n = 100). Between January and June 2016, subjects completed the THINC-it, which includes variants of the Choice Reaction Time Identification Task (IDN), One-Back Test, Digit Symbol Substitution Test, Trail Making Test-Part B, and the Perceived Deficits Questionnaire for Depression-5-item (PDQ-5-D).The THINC-it required approximately 10 to 15 minutes for administration and was capable of detecting cognitive

2017 Journal of Clinical Psychiatry

25. Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression Full Text available with Trip Pro

Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression The optimal tool for identifying postsroke depression (PSD) is yet to be identified. In the present study, we rely on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) as a meaningful criterion to investigate the psychometric properties of the HRQOLISP-E, a new context-specific screening tool for PSD developed from a large cross-cultural sample.We assessed (...) agreement with the HADS-D, sensitivity = 73.7%, specificity = 79.3%, and posterior test probability = 88% (95% CI = 84%-91%). The AUC was 0.81 (95% CI = 0.76-0.86). The HRQOLISP-E cut-off, corresponding to HADS-D score ≥ 8, was 20/21 (out of a total score of 30).Within limitations of using the HADS-D as a referent criterion, the present results provide justification for further development of the HRQOLISP-E as the first stroke-specific screening tool for depression.

2017 Behavioural neurology

26. Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability Full Text available with Trip Pro

Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability The optimal tool for identifying depression after stroke is yet to be identified. In the present study, we propose a new context-specific screening tool for PSD and examined its construct validity and reliability within existing data on recent stroke survivors.We assessed baseline data being collected as part of an intervention to improve one-year blood pressure control among recent (...) of the HRQOLISP-E as a context-specific screening tool for PSD through an investigation comparing the proposed measure against a referent-standard clinical diagnostic criteria such as the ICD 10 or Diagnostic and Statistical Manual of Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders.

2017 eNeurologicalSci

27. Depression and anxiety among hypertensive and diabetic primary health care patients: Could patients’ perception of their diseases control be used as a screening tool? Full Text available with Trip Pro

Depression and anxiety among hypertensive and diabetic primary health care patients: Could patients’ perception of their diseases control be used as a screening tool? To measure the frequency and identify risk factors of depression and anxiety among diabetic and hypertensive primary health care (PHC) patients. Also to assess whether patients' perception of their chronic diseases control and sleep disturbance could serve as screening tools for depression and anxiety. Methods: This cross (...) -sectional study of 368 PHC patients was conducted in AlKhobar city, Kingdom of Saudi Arabia between April and May 2015. Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7 were used as diagnostic tools for depression and anxiety. Results: Frequencies, cross-tabulations and logistic regression tests were performed. Patient's perception of chronic diseases control was significantly associated with the presence of depression and anxiety, while it was not seen in the tested disease control

2017 Saudi medical journal

28. The NoSAS score: A new and simple screening tool for obstructive sleep apnea syndrome in depressive disorder. Full Text available with Trip Pro

The NoSAS score: A new and simple screening tool for obstructive sleep apnea syndrome in depressive disorder. Since the clinical presentation of obstructive sleep apnea syndrome (OSAS) shares common features with major depressive (MDE), the screening of OSAS is challenging in this population. The aim of this study was to assess the effectiveness of the NoSAS score in predicting the presence of OSAS among participants with current MDE and to compare it with the performance of existing screening (...) the performance of screening tools for OSAS in MDE. The NoSAS score is a simple and efficient screening tool for OSAS in this population, and may be a helpful instrument for clinicians.Copyright © 2017 Elsevier B.V. All rights reserved.

2017 Journal of Affective Disorders

29. Process evaluation of a primary healthcare validation study of a culturally adapted depression screening tool for use by Aboriginal and Torres Strait Islander people: study protocol. Full Text available with Trip Pro

Process evaluation of a primary healthcare validation study of a culturally adapted depression screening tool for use by Aboriginal and Torres Strait Islander people: study protocol. Process evaluations are conducted alongside research projects to identify the context, impact and consequences of research, determine whether it was conducted per protocol and to understand how, why and for whom an intervention is effective. We present a process evaluation protocol for the Getting it Right research (...) project, which aims to determine validity of a culturally adapted depression screening tool for use by Aboriginal and Torres Strait Islander people. In this process evaluation, we aim to: (1) explore the context, impact and consequences of conducting Getting It Right, (2) explore primary healthcare staff and community representatives' experiences with the research project, (3) determine if it was conducted per protocol and (4) explore experiences with the depression screening tool, including

2017 BMJ open

30. Youth StepCare: a pilot study of an online screening and recommendations service for depression and anxiety among youth patients in general practice. Full Text available with Trip Pro

Youth StepCare: a pilot study of an online screening and recommendations service for depression and anxiety among youth patients in general practice. General Practitioners (GPs) are ideally placed to identify and manage emerging mental illness in young people, however, many report low levels of confidence in doing so. A web-based universal screening service delivered via a mobile tablet, Youth StepCare, was developed to assist GPs in identifying depression and anxiety symptoms in youth patients (...) were approached, 28 consented, and 19 completed the screener (67.9%). Nine reported symptoms of anxiety or depression, two of which were new cases (22.2%). GPs and practice staff were satisfied with the service, reporting that there was a need for the service and that they would use it again.The Youth StepCare service appears to be a useful tool for identifying youth with unidentified symptoms of mental illness that can be easily embedded into general practice. Further research would benefit from

2020 BMC Family Practice

31. Cognitive testing of the PHQ-9 for depression screening among pregnant and postpartum women in Kenya. Full Text available with Trip Pro

Cognitive testing of the PHQ-9 for depression screening among pregnant and postpartum women in Kenya. African women face high rates of depression, particularly during pregnancy or postpartum or after a recent HIV diagnosis. The Patient Health Questionnaire-9 (PHQ-9) depression screening tool has been quantitatively validated and extensively used to identify depression and link individuals to care. However, qualitative work is necessary to identify important opportunities to improve PHQ-9 (...) interview participants, 12 (60%) had scores ≥5, indicating depressive symptoms. Overall, participants found the scale acceptable as an interviewer-administered tool. Participants reported few problems related to comprehension but had difficulty answering items not relevant to their lives (e.g., "watching television") and double-barreled items (e.g., "poor appetite or overeating"). They were hesitant to endorse items related to "duties as a wife and mother" and suicidal ideation. Most participants had

2020 BMC Psychiatry

32. The psychometric properties of PHQ-4 anxiety and depression screening scale among out of school adolescent girls and young women in Tanzania: a cross-sectional study. Full Text available with Trip Pro

The psychometric properties of PHQ-4 anxiety and depression screening scale among out of school adolescent girls and young women in Tanzania: a cross-sectional study. Literature suggests that most mental disorders have their onset in childhood and adolescence, but go undiagnosed until adulthood. Shorter versions of the screening tools such as the Patient Health Questionnaire with four items (PHQ-4) may help to improve screening coverage. This study assessed the psychometric properties (...) two distinct components; GAD-2 (anxiety) and PHQ-2 (depression). Those who reported having suicidal thoughts and social function problems had significantly higher scores on PHQ-2, GAD-2, and PHQ-4 screening items (p < 0.01).The findings suggest that the PHQ-4 scale can reliably and validly screen for core symptoms of depression and anxiety among out of school AGYW. This tool is short and easy to administer. Thus, the PHQ-4 scale can be very useful in screening for anxiety and depression symptoms

2020 BMC Psychiatry

33. The validity and reliability of the PHQ-9 in screening for post-stroke depression. Full Text available with Trip Pro

The validity and reliability of the PHQ-9 in screening for post-stroke depression. Depression affects about 30% of stroke survivors within 5 years. Timely diagnosis and management of post-stroke depression facilitate motor recovery and improve independence. The original version of the Patient Health Questionnaire-9 (PHQ-9) is recognized as a good screening tool for post-stroke depression. However, no validation studies have been undertaken for the use of the Thai PHQ-9 in screening (...) for depression among Thai stroke patients.The objectives were to determine the criterion validity and reliability of the Thai PHQ-9 in screening for post-stroke depression by comparing its results with those of a psychiatric interview as the gold standard. First-ever stroke patients aged ≥45 years with a stroke duration 2 weeks-2 years were administered the Thai PHQ-9. The gold standard was a psychiatric interview leading to a DSM-5 diagnosis of depressive disorder and adjustment disorder with a depressed

2020 BMC Psychiatry

34. The validity and reliability of the Patient Health Questionnaire-9 for screening depression in primary health care patients in Botswana. Full Text available with Trip Pro

The validity and reliability of the Patient Health Questionnaire-9 for screening depression in primary health care patients in Botswana. The lack of locally validated screening instruments contributes to poor detection of depression in primary care. The Patient Health Questionnaire-9 (PHQ-9) is a brief and freely available screening tool which was developed for primary care settings; however, its accuracy may be affected by the population in which it is administered. This study aimed (...) to determine the validity and reliability of PHQ-9 for screening depression in a primary care population in Botswana.Data was collected from a conveniently selected sample of 257 adult primary care attendants. The Mini International Neuropsychiatric Interview (MINI) depression module was used as a gold standard to assess criterion validity.Sensitivity and specificity of the PHQ-9 for screening for major depression were 72.4 and 76.3 respectively at a cut off score of nine or more. The area under the ROC

2020 BMC Psychiatry

35. Validity and item response theory properties of the Patient Health Questionnaire-9 for primary care depression screening in Mozambique (PHQ-9-MZ). Full Text available with Trip Pro

Validity and item response theory properties of the Patient Health Questionnaire-9 for primary care depression screening in Mozambique (PHQ-9-MZ). Depression is one of the leading causes of disability in Mozambique; however, few patients with depression are identified in primary care. To our knowledge, there are no validated tools for depression screening in Mozambique. The aim of this study was to validate the Patient Health Questionnaire-9 (PHQ-9) for use in primary care settings (...) diagnostic tool.The majority of participants were female (74%), with a mean age of 28. Using the MINI 5.0-MZ, 43 (9%) of the sample tested positive for major depressive disorder. Items of the PHQ-9-MZ showed good discrimination and factor loadings. One latent factor of depression explained 54% of the variance in scores. Questions 3 (sleep) and 5 (appetite) had the lowest item discrimination and factor loadings. The PHQ-9-MZ showed good internal consistency, with a Cronbach's alpha of 0.84, and an area

2020 BMC Psychiatry

36. The Patient Health Questionnaire-9 as a Screening Tool for Depression in Individuals with Type 2 Diabetes Mellitus: The Maastricht Study (Abstract)

The Patient Health Questionnaire-9 as a Screening Tool for Depression in Individuals with Type 2 Diabetes Mellitus: The Maastricht Study To assess the psychometric properties and identify the best cutoff value of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in individuals with type 2 diabetes mellitus (T2DM).Observational population-based cohort study.The Maastricht Study.Individuals with and without T2DM (mean age 58.6 ± 8.1, 44.6% male) according to an oral glucose (...) analysis suggested a similar two-factor structure in both groups (affective and somatic symptoms).Patient Health Questionnaire-9 performs well as a screening tool for depressive symptoms in individuals with and without T2DM based on the cutoff value of 5, indicating that the PHQ-9 can be used in two-stage screening in primary care to select individuals with T2DM for further psychological evaluation.© 2016, Copyright the Authors Journal compilation © 2016, The American Geriatrics Society.

2016 EvidenceUpdates

37. Depression Screening Tools

Depression Screening Tools Depression Screening Tools Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Depression Screening Tools (...) Depression Screening Tools Aka: Depression Screening Tools , Major Depression Evaluation Scales II. Diagnostics: Children (age 7 or older) (CDI) Reynolds Child Depression Scale III. Diagnostics: Adolescents Reynolds Scale CES Depression Scale (CES-D) CES Depression Scale for Children (BDI) IV. Diagnostics: Adults ( ) (BDI) II PC (BDI-PC) CES Depression Scale (CES-D) V. Diagnostics: Elderly (BDI) CES Depression Scale (CES-D) (GDS, also in short version) VI. Diagnostics: Postpartum Depression VII

2018 FP Notebook

38. Depression in Children and Adolescents: Screening

of screening for suicide risk in primary care settings, including among adolescents (I statement). Other USPSTF recommendations on mental health topics pertaining to children and adolescents, including illicit drug and alcohol use, can be found on the USPSTF Web site ( ). Implementation Many screening tools are available to identify depression in children and adolescents, and some have been used in primary care. The number of items in each tool, the administrative time required to complete them (...) Depression in Children and Adolescents: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Adolescents aged 12 to 18 years The USPSTF recommends screening for major depressive disorder (MDD) in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. B Children aged 11 years or younger The USPSTF

2016 U.S. Preventive Services Task Force

39. Depression in Adults: Screening

, Le HN, Perry DF. A comparison of three screening tools to identify perinatal depression among low-income African American women. J Affect Disord . 2012;136(1-2):155-62. 9. Williams JW Jr, Mulrow CD, Kroenke K, Dhanda R, Badgett RG, Omori D, et al. Case-finding for depression in primary care: a randomized trial. Am J Med. 1999;106:36-43. 10. US Preventive Services Task Force. Screening for depression in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med . 2009;151 (...) Depression in Adults: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation General adult population, including pregnant and postpartum women The USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. B View

2016 U.S. Preventive Services Task Force

40. Development and evaluation of a mobile-optimized daily self-rating depression screening app: A preliminary study. Full Text available with Trip Pro

algorithm (A) scores. Of the 20 participants, 4 scored at or above the cut-off criterion (≥13) on either the original K-CESD-R (n = 4) or the mobile K-CESD-R converted with algorithm (A) (n = 3) or algorithm (B) (n = 1). However, all participants were assessed as being below threshold for a diagnosis of a mental disorder during a clinician-administered diagnostic interview. Therefore, the K-CESD-R Mobile app using algorithm (B) could be a more potential candidate for a depression screening tool than (...) Development and evaluation of a mobile-optimized daily self-rating depression screening app: A preliminary study. The aims of this study were to design a mobile app that would record daily self-reported Korean version of the Center for Epidemiologic Studies Depression Scale-Revised (K-CESD-R) ratings in a "Yes" or "No" format, develop two different algorithms for converting mobile K-CESD-R scores in a binary format into scores in a 5-point response format, and determine which algorithm would

2018 PLoS ONE

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>